Chemerin, encoded by the RARRES2 gene, is an adipokine with potent immunometabolic functions mediated through CMKLR1, GPR1, and CCRL2. Its regulation is tissue- and context-dependent, conferring dual protective and pathogenic roles. In the upper GI tract, chemerin facilitates immune tolerance in Barrett’s adenocarcinoma and promotes invasion in esophageal and gastric cancers. In pancreatic disease, it acts as a biomarker of acute and chronic injury, while modulating β-cell function and carcinogenesis. In the liver, chemerin contributes to NAFLD/NASH pathogenesis with both anti-inflammatory and pro-steatotic actions, predicts prognosis in cirrhosis, and demonstrates tumor-suppressive potential in hepatocellular carcinoma. In IBD, chemerin exacerbates colitis via impaired macrophage polarization, yet protects epithelial antimicrobial defense, underscoring its context-specific biology. Collectively, these findings position chemerin as a versatile regulator bridging metabolic dysfunction, inflammation, and gastrointestinal malignancy, and as a potential candidate for biomarker development and therapeutic intervention.
1 January 2026 in Srpski arhiv za celokupno lekarstvo
Introduction/Objective. The escalating resistance of numerous pathogens to currently available therapeutic agents has sparked a renewed interest in the search of novel antimicrobial compounds. Plants have become a potentially valuable source of these compounds. This study aimed to assess the direct and indirect antimicrobial effects of Onosma visianii Clem root extract on reference and clinical bacterial strains using broth microdilution and a modified ethidium bromide/acridine orange (EB/AO) fluorescence assay. Methods. The ethanolic extract obtained from the dried root of Onosma visianii Clem was used to determine the minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) by broth microdilution, as well as the half maximal inhibitory concentration ( \mathrm{IC_{50}} ) values for reference and clinical bacterial strains. The EB/AO fluorescence method was employed to assess the effect on efflux pumps in methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VRE), using 50% of the MIC value of the extract. Results. The MIC, MBC, and \mathrm{IC_{50}} values for Gram-positive bacteria were all below 15 μg/mL. The extract demonstrated strong antibacterial activity against VRE and, in particularly, against MRSA isolates (MIC = 7.81 μg/mL and MBC = 7.81 μg/mL). Furthermore, treatment with 50% of the MIC concentration produced a significant inhibitory effect on efflux pumps in Gram-positive bacteria, ranging from 18% to 26% compared with untreated cells. Conclusion. The root extract of Onosma visianii Clem exhibited antimicrobial activity against both Grampositive and Gram-negative bacteria, with particularly strong effects against VRE and MRSA. In addition, the observed inhibition of bacterial efflux pumps underscores its promise as a candidate for pharmacological evaluation of the antibiotic properties of the Onosma visianii Clem root extract.
Introduction. Emphysematous pyelonephritis (EPN) is a rare type of severe kidney infection characterized by gas formation in the renal parenchyma, collecting system, or surrounding perinephric tissues. Emphysematous cystitis (EC) is a rare, potentially fatal condition characterized by the presence of gas in the bladder wall and lumen. We present a rare case of EPN with EC in a patient with diabetes mellitus (DM). Case report. A 38-year-old female patient with poorly regulated DM was referred to the Department of Urology at the General Hospital in Novi Pazar, Serbia, with malaise, fever, and flank and suprapubic pain. After physical examination, laboratory analyses, and radiological diagnostics, the diagnosis of bilateral EPN with EC was established. Throughout the hospitalization, the patient remained hemodynamically stable with pre-served diuresis. The patient?s urine and blood cultures were negative. The patient was treated with intravenous fluids and antibiotics (metronidazole, vancomycin, and meropenem). No other invasive form of treatment was needed due to successful conservative treatment. Conclusion. A timely diagnosis and rapid inclusion of specific antibiotic therapies enables the avoidance of the need for invasive forms of treatment in patients with EPN and EC. The conservative management of the presented patient was successful.